If it wasn't for you know what happening late last week, the TLX SP should be significantly higher IMO !!!
Telix on past history of releasing announcements, there should be no let up for this week .. FC !!

News Flow Highlights last week
The week's releases were of significant excellence..

> Nasdaq Listed TLX hit a high of $28.31

> Illuccix Germany

> Illuccix Greece

> Investor Day NYC

> Gozellix Launched in USA for Sale

> UBS maintained rating of $36.00AUD

> Wedbush $22.00US = $33.89

> HC Posters suggested earnings increases from Gozellix

> TLX SP Nasdaq closed $24.94 AUD on Friday..


---------------------------------------------------------------

Analysts Offer Insights on Healthcare Companies: Nurix Therapeutics (NRIX) and Telix Pharmaceuticals (OtherTLPPF)

Howard KimJun 13, 2025, 04:30 AM

A+

A-

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Telix Pharmaceuticals (TLPPF – Research Report) with bullish sentiments.

Confident Investing Starts Here:

• Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
• Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter

Telix Pharmaceuticals (TLPPF)

In a report released today, Tara Bancroft from TD Cowen maintained a Buy rating on Telix Pharmaceuticals, with a price target of A$35.00. The company’s shares closed last Wednesday at $17.00.

According to TipRanks.com, Bancroft ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -9.9% and a 37.1% success rate. Bancroft covers the Healthcare sector, focusing on stocks such as Day One Biopharmaceuticals, Protagonist Therapeutics, and Whitehawk Therapeutics.

Currently, the analyst consensus on Telix Pharmaceuticals is a Strong Buy with an average price target of $22.66.